应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09996 沛嘉医疗-B
停牌 04-19 09:20:55
3.660
+0.000
0.00%
最高
3.660
最低
3.660
成交量
0.00
今开
3.660
昨收
3.660
日振幅
0.00%
总市值
24.86亿
流通市值
24.86亿
总股本
6.79亿
成交额
0.00
换手率
0.00%
流通股本
6.79亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
新华医疗获得外观设计专利授权:“单面医疗器械检查打包台”
证券之星 · 02:10
新华医疗获得外观设计专利授权:“单面医疗器械检查打包台”
安必平最新公告:取得HER2抗体试剂(免疫组织化学)医疗器械注册证
证券之星 · 04-18 16:18
安必平最新公告:取得HER2抗体试剂(免疫组织化学)医疗器械注册证
安必平(688393.SH)收到HER2抗体试剂(免疫组织化学)医疗器械注册证
智通财经 · 04-18 15:36
安必平(688393.SH)收到HER2抗体试剂(免疫组织化学)医疗器械注册证
新产业(300832.SZ)取得多项医疗器械注册证
智通财经网 · 04-17 20:16
新产业(300832.SZ)取得多项医疗器械注册证
九强生物最新公告:Rh血型分型卡(微柱凝胶法)获医疗器械注册证
证券之星 · 04-17 17:05
九强生物最新公告:Rh血型分型卡(微柱凝胶法)获医疗器械注册证
九强生物:Rh血型分型卡(微柱凝胶法)取得医疗器械注册证
中国财富通 · 04-17 16:46
九强生物:Rh血型分型卡(微柱凝胶法)取得医疗器械注册证
九强生物(300406.SZ)取得一项医疗器械注册证书
智通财经 · 04-17 15:45
九强生物(300406.SZ)取得一项医疗器械注册证书
周轶洋:投资人从那些维度看公司 | 钛资本债权组
钛媒体APP · 04-17 14:37
周轶洋:投资人从那些维度看公司 | 钛资本债权组
迈克生物(300463.SZ)取得一项医疗器械注册证
智通财经 · 04-16 19:22
迈克生物(300463.SZ)取得一项医疗器械注册证
AI+赋能医疗器械,国内企业创新能力提升,关注医疗器械ETF(562600)等产品布局机会
每日经济新闻 · 04-16
AI+赋能医疗器械,国内企业创新能力提升,关注医疗器械ETF(562600)等产品布局机会
诺唯赞最新公告:子公司系列诊断试剂产品取得医疗器械注册证
证券之星 · 04-14
诺唯赞最新公告:子公司系列诊断试剂产品取得医疗器械注册证
诺唯赞(688105.SH)子公司开发AD系列诊断试剂产品取得医疗器械注册证
智通财经 · 04-14
诺唯赞(688105.SH)子公司开发AD系列诊断试剂产品取得医疗器械注册证
中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地
证券时报 · 04-14
中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地
锐盟医疗完成A轮融资,融资额数千万人民币,投资方为紫金港资本、好一多等
证券之星 · 04-12
锐盟医疗完成A轮融资,融资额数千万人民币,投资方为紫金港资本、好一多等
科华生物最新公告:两款试剂盒产品获得医疗器械注册证
证券之星 · 04-12
科华生物最新公告:两款试剂盒产品获得医疗器械注册证
科华生物(002022.SZ)收到两项医疗器械注册证
智通财经 · 04-12
科华生物(002022.SZ)收到两项医疗器械注册证
艾柯医疗IPO终止:3年收入不足百万元 累亏2.28亿元
GPLP · 04-12
艾柯医疗IPO终止:3年收入不足百万元 累亏2.28亿元
上海先锋控股(1345.HK):医疗器械构建业绩增长引擎 创新产品助力公司战略转型
权证网 · 04-12
上海先锋控股(1345.HK):医疗器械构建业绩增长引擎 创新产品助力公司战略转型
净利润6000万的医疗器械公司,科创板IPO失败
市场资讯 · 04-11
净利润6000万的医疗器械公司,科创板IPO失败
加载更多
公司概况
公司名称:
沛嘉医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司,该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。
发行价格:
--
{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":3.66,"timestamp":1713489655173,"preClose":3.66,"halted":3,"volume":0,"delay":0,"floatShares":679326808,"shares":679326808,"eps":-0.62419575,"marketStatus":"停牌","marketStatusCode":3,"change":0,"latestTime":"04-19 09:20:55","open":3.66,"high":3.66,"low":3.66,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.6241957765266891,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713502800000},"adr":0,"listingDate":1589472000000,"adjPreClose":3.66,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2428854365","title":"新华医疗获得外观设计专利授权:“单面医疗器械检查打包台”","url":"https://stock-news.laohu8.com/highlight/detail?id=2428854365","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428854365?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:10","pubTimestamp":1713463849,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示新华医疗新获得一项外观设计专利授权,专利名为“单面医疗器械检查打包台”,专利申请号为CN202330655975.8,授权日为2024年4月19日。今年以来新华医疗新获得专利授权68个,较去年同期减少了37.04%。结合公司2023年年报财务数据,2023年公司在研发方面投入了4.43亿元,同比增10.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041900002242.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428551646","title":"安必平最新公告:取得HER2抗体试剂(免疫组织化学)医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428551646","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428551646?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:18","pubTimestamp":1713428309,"startTime":"0","endTime":"0","summary":"安必平公告,公司于近日收到由国家药品监督管理局颁发的HER2抗体试剂(免疫组织化学)的《医疗器械注册证(体外诊断试剂)》。该试剂是免疫组织化学平台用于定性检测乳腺癌患者的HER2抗原,用于曲妥珠单抗(赫赛汀)的伴随诊断检测注册证。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041800030096.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428555535","title":"安必平(688393.SH)收到HER2抗体试剂(免疫组织化学)医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428555535","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428555535?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:36","pubTimestamp":1713425818,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)发布公告,公司于近日收到由国家药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》,产品名称为HER2抗体试剂(免疫组织化学),该试剂是免疫组织化学平台用于定性检测乳腺癌患者的HER2抗原,用于曲妥珠单抗(赫赛汀)的伴随诊断检测注册证。与公司现有的HER2基因检测试剂盒(荧光原位杂交法)联合使用符合检测指南要求,使公司成为国产唯一可提供乳腺癌HER2病理双技术检测及用药指导方案的企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104510.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428312977","title":"新产业(300832.SZ)取得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428312977","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428312977?lang=zh_cn&edition=full","pubTime":"2024-04-17 20:16","pubTimestamp":1713356191,"startTime":"0","endTime":"0","summary":"新产业(300832.SZ)公告,公司收到了1项国家药品监督管理局、4项广东省药品...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104118.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428919043","title":"九强生物最新公告:Rh血型分型卡(微柱凝胶法)获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428919043","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428919043?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:05","pubTimestamp":1713344710,"startTime":"0","endTime":"0","summary":"九强生物公告,公司于2024年4月17日收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为Rh血型分型卡(微柱凝胶法),该产品用于Rh血型系统的D、C、c、E、e抗原的检测,仅用于临床检验,不用于血源筛查。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041700034600.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428396955","title":"九强生物:Rh血型分型卡(微柱凝胶法)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2428396955","media":"中国财富通","top":-1,"share":"https://www.laohu8.com/m/news/2428396955?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:46","pubTimestamp":1713343599,"startTime":"0","endTime":"0","summary":"中国财富通4月17日 - 九强生物(300406)公告称,公司收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为Rh血型分型卡(微柱凝胶法),该产品医疗器械注册证的取得,丰富了公司产品类别。取得医疗器械注册证有利于增强公司的核心竞争力,对公司未来发展具有正面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=CGmb7y94W2Y%3D","is_publish_highlight":false,"gpt_icon":0},{"id":"2428062367","title":"九强生物(300406.SZ)取得一项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428062367","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428062367?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:45","pubTimestamp":1713339923,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)公告,公司收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为:Rh血型分型卡(微柱凝胶法)。本产品用于Rh血型系统的D、C、c、E、e抗原的检测。仅用于临床检验,不用于血源筛查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103812.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428780369","title":"周轶洋:投资人从那些维度看公司 | 钛资本债权组","url":"https://stock-news.laohu8.com/highlight/detail?id=2428780369","media":"钛媒体APP","top":-1,"share":"https://www.laohu8.com/m/news/2428780369?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:37","pubTimestamp":1713335842,"startTime":"0","endTime":"0","summary":"文 | 钛资本研究院医疗器械行业正迎来一个充满活力与创新的黄金发展期。得益于国家政策的强劲助推,这一行业不仅展现出前所未有的市场蓝海和巨大增长潜力,而且行业内部的合作与竞争亦成为驱动医疗器械向更高端、智能化方向迈进的强大动力。医疗器械方面的投资趋势和投资逻辑是什么?近期钛资本邀请到资深投资人周轶洋进行...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O1-LIZWVj-M4uZ6v7emd598nIIHOz4bRM-KhUOdeLw1qcAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O1-LIZWVj-M4uZ6v7emd598nIIHOz4bRM-KhUOdeLw1qcAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240417A04TWV00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240417A04TWV00","is_publish_highlight":false,"gpt_icon":0},{"id":"2427370828","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2427370828","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427370828?lang=zh_cn&edition=full","pubTime":"2024-04-16 19:22","pubTimestamp":1713266538,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈克生物(300463.SZ)公告,公司近日收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为:幽门螺杆菌抗原检测试剂盒(胶体金法)。幽门螺杆菌抗原检测试剂盒(胶体金法)主要用于体外定性检测人粪便样本中的幽门螺杆菌抗原,辅助诊断人群中幽门螺杆菌的感染情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103466.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427850436","title":"AI+赋能医疗器械,国内企业创新能力提升,关注医疗器械ETF(562600)等产品布局机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2427850436","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2427850436?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:32","pubTimestamp":1713231146,"startTime":"0","endTime":"0","summary":"第89届中国国际医疗器械博览会于4月11~14日在上海举办,国内相关领先医疗器械公司携部分首发产品或新技术产品积极参展,展示出国内医疗器械公司强大的创新研发能力。高端影像设备、数字化与智能化、AI医疗等产业链具备较强创新能力和创新意识,AI+模式也有望重塑产业格局,提升生产效率和服务能力。华夏中证全指医疗器械ET...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Oq6USFArECnz2nGqwxAvlZ4WNjZG0FqeMQTNNos4PpGcQAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Oq6USFArECnz2nGqwxAvlZ4WNjZG0FqeMQTNNos4PpGcQAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240416A01NMA00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240416A01NMA00","is_publish_highlight":false,"gpt_icon":0},{"id":"2427808236","title":"诺唯赞最新公告:子公司系列诊断试剂产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2427808236","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2427808236?lang=zh_cn&edition=full","pubTime":"2024-04-14 16:11","pubTimestamp":1713082274,"startTime":"0","endTime":"0","summary":"诺唯赞公告,公司全资子公司南京诺唯赞医疗科技有限公司开发的系列诊断试剂产品于近日取得《医疗器械注册证》。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041400001427.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427084596","title":"诺唯赞(688105.SH)子公司开发AD系列诊断试剂产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2427084596","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427084596?lang=zh_cn&edition=full","pubTime":"2024-04-14 15:54","pubTimestamp":1713081251,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺唯赞 发布公告,公司全资子公司南京诺唯赞医疗科技有限公司开发的系列诊断试剂产品于近日取得《医疗器械注册证》,分别为β淀粉样蛋白1-40检测试剂盒、β淀粉样蛋白1-42检测试剂盒、磷酸化Tau217蛋白检测试剂盒(化学发光法、磷酸化Tau181蛋白(p-Tau181)检测试剂盒(化学发光法)、神经丝轻链蛋白(NfL)检测试剂盒(化学发光法)及胶质纤维酸性蛋白(GFAP)检测试剂盒(化学发光法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102213.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427084883","title":"中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2427084883","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2427084883?lang=zh_cn&edition=full","pubTime":"2024-04-14 15:48","pubTimestamp":1713080888,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,中国航天科技集团消息,近日,中国航天科技集团有限公司一院北京精密机电控制设备研究所与华润医药商业集团医疗器械有限公司签订了战略合作协议,双方将充分发挥各自优势和资源积累,共同推动国产高端医疗装备产业高地建设。根据合作内容,双方将就医疗器械产品开发、市场营销体系建立等方面积极探索多样化合作模式,使彼此的技术资源、市场资源同频共振,进一步加快技术成果转化,快速建立市场销售渠道,发挥产业资源协同效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404141548108779a377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404141548108779a377&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426782785","title":"锐盟医疗完成A轮融资,融资额数千万人民币,投资方为紫金港资本、好一多等","url":"https://stock-news.laohu8.com/highlight/detail?id=2426782785","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426782785?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:46","pubTimestamp":1712922364,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于4月11日公布的信息整理,锐盟(深圳)医疗科技有限公司完成A轮融资,融资额数千万人民币,参与投资的机构包括紫金港资本,好一多。凭借创业团队在医疗器械领域丰富的 研发销售经验和强大的医院市场资源,重塑医疗器械产品和运营模式, 发展目标是在医疗器械领域未来新的价值链中做大做强,成为新业态 医疗器械的引领者。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041200038896.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426720371","title":"科华生物最新公告:两款试剂盒产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2426720371","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426720371?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:57","pubTimestamp":1712912251,"startTime":"0","endTime":"0","summary":"科华生物公告,公司近日收到国家药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂),产品包括戊型肝炎病毒IgM抗体检测试剂盒(化学发光法)、乙型肝炎病毒核心IgM抗体检测试剂盒(化学发光法)。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041200030652.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426725812","title":"科华生物(002022.SZ)收到两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2426725812","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426725812?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:51","pubTimestamp":1712908268,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科华生物(002022.SZ)发布公告,公司收到国家药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)。产品名称为:戊型肝炎病毒IgM抗体检测试剂盒(化学发光法)、乙型肝炎病毒核心IgM抗体检测试剂盒(化学发光法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101637.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427760638","title":"艾柯医疗IPO终止:3年收入不足百万元 累亏2.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427760638","media":"GPLP","top":-1,"share":"https://www.laohu8.com/m/news/2427760638?lang=zh_cn&edition=full","pubTime":"2024-04-12 13:10","pubTimestamp":1712898647,"startTime":"0","endTime":"0","summary":"4月11日,上交所发布公告称,艾柯医疗器械 ( 北京 ) 股份有限公司(下称“艾柯医疗”)上市审核状态变更为“终止”,原因系该公司及保荐人中信证券主动撤回科创板上市申请。 招股书显示,艾柯....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240412A04LX900","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240412A04LX900","is_publish_highlight":false,"gpt_icon":0},{"id":"2426593241","title":"上海先锋控股(1345.HK):医疗器械构建业绩增长引擎 创新产品助力公司战略转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2426593241","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2426593241?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:10","pubTimestamp":1712884259,"startTime":"0","endTime":"0","summary":"医疗器械板块点燃业绩增长新引擎上海先锋控股2023年财报显示,公司在医疗器械板块收入达到8.29亿元,同比大幅增长230.4%;毛利为3.59亿元,同比增长185.8%,板块业绩表现亮眼。本次合作为上海先锋控股在医疗器械领域的发展注入了强大的技术支持和创新活力,进一步丰富产品线的创新能力。另外,上海先锋控股正在积极布局该两款产品及后续产品的国产化生产,为公司向产销一体、创新高新的战略转型方向提供积极助力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412091105876b4af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412091105876b4af6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426261686","title":"净利润6000万的医疗器械公司,科创板IPO失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2426261686","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426261686?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:01","pubTimestamp":1712847660,"startTime":"0","endTime":"0","summary":"4月10日,北京朗视仪器股份有限公司上交所科创板IPO审核状态变更为“终止”。在近2年的兜兜转转之后,朗视仪器的IPO最终还是以失败而告终。和此前多家终止科创板IPO的医疗器械企业不一样,朗视仪器并非采用科创板“标准五”申报,而是采用“标准一”,即“预计市值不低于人民币10亿元,最近两年净利润均为正且累计净利润不低于人民币5,000万元”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/stockzmt/2024-04-11/doc-inarnqvs7829281.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockzmt/2024-04-11/doc-inarnqvs7829281.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1956},{"period":"3month","weight":-0.3081},{"period":"6month","weight":-0.4068},{"period":"1year","weight":-0.6579},{"period":"ytd","weight":-0.5047}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司,该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087602},{"month":2,"riseRate":0.5,"avgChangeRate":0.022444},{"month":3,"riseRate":0.25,"avgChangeRate":-0.199645},{"month":4,"riseRate":0.5,"avgChangeRate":0.028744},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.097949},{"month":6,"riseRate":0.75,"avgChangeRate":0.16943},{"month":7,"riseRate":0.25,"avgChangeRate":-0.017553},{"month":8,"riseRate":0.25,"avgChangeRate":-0.138554},{"month":9,"riseRate":0.25,"avgChangeRate":-0.0288},{"month":10,"riseRate":0.5,"avgChangeRate":-0.006761},{"month":11,"riseRate":0.5,"avgChangeRate":-0.006115},{"month":12,"riseRate":0.5,"avgChangeRate":0.08022}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}